Medtronic

Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients
"The onus is on us as cardiologists to make sure we offer the very best possible devices for our patients with the available data that we have," interventional cardiologist Anene Ukaigwe, MD, explained.
Women with severe aortic stenosis remain underdiagnosed, undertreated—here’s how cardiologists can make a difference
Women with cardiovascular disease are consistently underdiagnosed and undertreated compared to men, and those disparities are true for aortic stenosis as well. Women with symptomatic severe AS are up to 35% less likely than men to undergo aortic valve replacement, for example, and they often have to wait longer just to be referred for further care.
TAVR technology keeps evolving, improving outcomes without compromising valve performance
TAVR is a go-to treatment for symptomatic severe aortic stenosis in much of the world, thanks in large part to the hard work of research teams that never stop looking for new, innovative ways to make the technology more effective.
Q&A: How supra-annular, self-expanding TAVR valves open up options for future interventions
TAVR procedures have surged more than 30% since 2020, with more than 107,000 patients receiving a new prosthetic valve in 2023 alone. As this trend continues, it’s increasingly important that cardiologists consider the long-term impact on future coronary interventions patients may need.
Get SMART: Cardiologist says new TAVR data changed his perspective on treating women with symptomatic severe AS
Physicians and researchers complete thousands of clinical trials each year, but some findings prove far more significant than others. For cardiologist Dharmesh Patel, MD, the results of the SMART trial have changed the way he’s managing and recommending treatment for women with symptomatic severe aortic stenosis.

Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients

"The onus is on us as cardiologists to make sure we offer the very best possible devices for our patients with the available data that we have," interventional cardiologist Anene Ukaigwe, MD, explained.

Women with severe aortic stenosis remain underdiagnosed, undertreated—here’s how cardiologists can make a difference

Women with cardiovascular disease are consistently underdiagnosed and undertreated compared to men, and those disparities are true for aortic stenosis as well. Women with symptomatic severe AS are up to 35% less likely than men to undergo aortic valve replacement, for example, and they often have to wait longer just to be referred for further care.

doctor examines patient data on their tablet

TAVR technology keeps evolving, improving outcomes without compromising valve performance

TAVR is a go-to treatment for symptomatic severe aortic stenosis in much of the world, thanks in large part to the hard work of research teams that never stop looking for new, innovative ways to make the technology more effective.

Q&A: How supra-annular, self-expanding TAVR valves open up options for future interventions

TAVR procedures have surged more than 30% since 2020, with more than 107,000 patients receiving a new prosthetic valve in 2023 alone. As this trend continues, it’s increasingly important that cardiologists consider the long-term impact on future coronary interventions patients may need.

old woman or doctor shaking hands with patient

Get SMART: Cardiologist says new TAVR data changed his perspective on treating women with symptomatic severe AS

Physicians and researchers complete thousands of clinical trials each year, but some findings prove far more significant than others. For cardiologist Dharmesh Patel, MD, the results of the SMART trial have changed the way he’s managing and recommending treatment for women with symptomatic severe aortic stenosis.

Q&A: Interventional cardiologist breaks down SMART data and TAVR valve performance in patients with small annuli

Some of the most talked about data at ACC.24 were the results of a late-breaking clinical trial comparing different transcatheter aortic valve replacement (TAVR) valves in patients with a small aortic annulus.

Good to great: 5 ways to help sonographers deliver better echocardiograms and improve the diagnosis of severe AS

Hospitals should be making every effort to help sonographers deliver better, more accurate echocardiograms and improve the diagnosis of severe aortic stenosis. If you take care of your sonographers, your sonographers will take care of you.

‘A huge victory for patient care’: Next-gen TAVR valve helps cardiologists target more patients

“The Evolut FX system is an improvement over previous Evolut system devices and it delivers better overall results to our patients,” says interventional cardiologist Guilherme Attizzani, MD. “It is an ideal solution for a majority of our patients.”